NCT05869968View on ClinicalTrials.gov

SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

RecruitingOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2027

Conditions

Spinal Cord InjuriesTraumatic Spinal Cord InjuryHealthy ControlsFlu VaccineCOVID-19 Vaccine

Trial Locations (1)

11030

RECRUITING

Northwell Health, Manhasset

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

collaborator

United States Department of Defense

FED

collaborator

New York State Department of Health

OTHER_GOV

lead

Northwell Health

OTHER

NCT05869968 - SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI | Biotech Hunter | Biotech Hunter